Eleftha 440 Mg Trastuzumab Injection

Description

Introduction Of Eleftha 440mg Injection:

Eleftha 440mg Injection is used in the treatment of breast and stomach cancer. It works by killing the cancer cells by inhibiting HER2 (human epidermal growth factor receptor protein).

Eleftha 440mg Injection is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

The most common side effects of this medicine include nausea, headache, rash, insomnia, and infection. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels. You must have to inform your doctor if you experience breathlessness, cough, shivering, swelling of legs and arm.

Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.

Uses Of Eleftha 440mg Injection:

Eleftha 440mg Injection is used to treat certain types of breast and stomach cancers that produce too much HER2. The detailed uses of Eleftha 440 Injection are as follows:

• HER2-positive breast cancer: Eleftha 440 Injection helps by targeting and blocking the HER2 receptors on cancer cells, which slows down tumor growth and reduces the risk of the cancer returning after surgery or chemotherapy.
• HER2-positive metastatic stomach (gastric) cancer: Eleftha 440 Injection works in combination with chemotherapy to slow the progression of advanced stomach or gastroesophageal junction cancers that overexpress the HER2 protein.

Benefits Of Eleftha 440mg Injection:

Eleftha 440mg Injection offers significant clinical benefits for individuals facing specific types of aggressive cancers. By focusing directly on cancer cells rather than all rapidly dividing cells, it helps limit damage to healthy tissues, resulting in a more targeted approach to cancer care. Key benefits include:

• Reduced risk of cancer recurrence: When used after surgery for early-stage breast cancer, it significantly lowers the chances of the cancer coming back.
• Extended survival times: In advanced or metastatic cases of breast and stomach cancer, it helps control tumour growth, which can help extend life and improve comfort.
• Synergy with chemotherapy: It enhances the effectiveness of standard chemotherapy drugs, making the overall treatment regimen more successful at shrinking tumours.

Side effects of Eleftha 440mg Injection:

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.

Common side effects of Eleftha:

• Headache
• Loose And Watery Stools
• Fever
• Infections
• Heart Failure
• Trouble Falling/ Staying Asleep
• Cough

Mechanism Of Action Eleftha 440 mg Injection:

Eleftha 440mg Injection is a recombinant IgG1 monoclonal antibody. It works against the HER2 (human epidermal growth factor receptor protein) receptors which are responsible for the over-proliferation of cancer cells in breast cancer and stomach cancer cells. It destroys the cancer cells by inhibiting HER2. It also inhibits various cancer-causing downstream signaling pathways.

Contact Us